{"altmetric_id":2868080,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["214231992002679"],"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[53285],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":1,"unique_users":["F1000Research"],"posts_count":1}},"selected_quotes":["APOC3 may not be an ideal predictor for risk of ischemic vascular disease in the Chinese population."],"citation":{"authors":["Liang Tang","Zhi-Peng Cheng","Qing-Yun Wang","Wei Zeng","Hui Liu","Ying-Ying Wu","Bei Hu","Yu Hu"],"doi":"10.12688\/f1000research.5676.1","first_seen_on":"2014-11-10T03:42:54+00:00","funders":["niehs"],"issns":[],"journal":"F1000Research","last_mentioned_on":1418307022,"links":["http:\/\/f1000research.com\/articles\/3-270#.VGAyEWuhuzQ.facebook","http:\/\/f1000research.com\/articles\/3-270\/v1"],"pmid":"25664173","pubdate":"2014-11-07T00:00:00+00:00","title":"<i>APOC3<\/i> may not be a predictor of risk of ischemic vascular disease in the Chinese population","type":"article","volume":"3","mendeley_url":"http:\/\/www.mendeley.com\/research\/apoc3-not-predictor-risk-ischemic-vascular-disease-chinese-population-1"},"altmetric_score":{"score":7.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.75},"context_for_score":null},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Master":1,"Professor":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":1}}},"geo":{"twitter":{"GB":1},"mendeley":{"TR":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/F1000Research\/status\/543045126319509504","license":"datasift","citation_ids":[2868080],"posted_on":"2014-12-11T14:10:22+00:00","author":{"name":"F1000Research","url":"http:\/\/f1000research.com","image":"https:\/\/pbs.twimg.com\/profile_images\/471620412594335745\/_fMPwwQw_normal.png","description":"An Open Research publishing platform for life scientists. Immediate publication, transparent refereeing, all data included, no editorial bias. Part of @F1000.","id_on_source":"F1000Research","tweeter_id":"59126394","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":17340},"tweet_id":"543045126319509504"}],"facebook":[{"title":"F1000Research Article: APOC3 may not be a predictor of risk of ischemic...","url":"https:\/\/www.facebook.com\/214231992002679\/posts\/732093373549869","license":"public","citation_ids":[2868080],"posted_on":"2014-12-11T14:10:22+00:00","summary":"APOC3 may not be an ideal predictor for risk of ischemic vascular disease in the Chinese population. http:\/\/ow.ly\/FBZzn f1000research.com","author":{"name":"F1000Research","url":"https:\/\/www.facebook.com\/214231992002679","facebook_wall_name":"F1000Research","image":"https:\/\/graph.facebook.com\/214231992002679\/picture","id_on_source":"214231992002679"}}],"blogs":[{"title":"New on F1000Research \u2013 8 December 2014","url":"http:\/\/blog.f1000research.com\/2014\/12\/08\/new-on-f1000research-8-december-2014\/","citation_ids":[2888649,2889239,2939227,2868080,2957362],"posted_on":"2014-12-08T15:12:00+00:00","summary":"A selection of new content on&nbsp;F1000Research&nbsp;from the past week. To receive notification of all new articles,&nbsp;sign up for our table of contents alerts. Featured article A common feature pharmacophore for FDA-approved drugs inhibiting the Ebol","author":{"name":"Discussions \u2013 F1000 Research","url":"http:\/\/blog.f1000research.com","description":"Open Science \u2022 Open Data \u2022 Open Peer Review"}}]}}